(JRUD) JPMorgan s (Ireland) ICAV - - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BJ06C044 • US Large-Cap Blend Equity
JRUD: US Stocks, Large Cap, Mid Cap, Index Fund
This ETF is structured as an Irish ICAV, offering a regulated, UCITS-compliant vehicle for investors seeking exposure to U.S. large-cap equities. It tracks the Morningstar US Large-Mid NR USD index, which focuses on a mix of large and mid-capitalization companies in the U.S. market. The fund is listed on XETRA under the ticker JRUD, making it accessible to European investors.
The ETFs investment strategy is designed to replicate the performance of its underlying index, which is constructed using Morningstars proprietary research and analysis. The index typically includes companies with strong fundamental characteristics, balancing growth and value metrics. The funds AUM of 6.044 billion EUR reflects its popularity among institutional and retail investors seeking diversified U.S. equity exposure.
As a UCITS ETF, it must adhere to strict European regulatory standards, ensuring transparency, liquidity, and investor protections. The fund is particularly appealing to investors who want cost-effective access to the U.S. market without the complexities of directly managing individual securities. Its listing on XETRA also ensures efficient trading and settlement within the European market structure.
For fund managers and institutional investors, this ETF offers a liquid and scalable way to gain exposure to U.S. large-cap equities. Its tracking error is typically low due to its passive replication strategy, and its expense ratio is competitive within the UCITS ETF space. The funds structure also allows for efficient tax treatment under Irish regulations, making it a tax-efficient option for international investors.
Additional Sources for JRUD ETF
JRUD ETF Overview
Market Cap in USD | 6,544m |
Category | US Large-Cap Blend Equity |
IPO / Inception | 2019-12-16 |
JRUD ETF Ratings
Growth 5y | 90.4% |
Fundamental | - |
Dividend | 20.8% |
Rel. Strength | -1.44 |
Analysts | - |
Fair Price Momentum | 52.56 EUR |
Fair Price DCF | - |
JRUD Dividends
Dividend Yield 12m | 0.62% |
Yield on Cost 5y | 1.50% |
Annual Growth 5y | -4.46% |
Payout Consistency | 94.2% |
JRUD Growth Ratios
Growth Correlation 3m | -59.6% |
Growth Correlation 12m | 83.2% |
Growth Correlation 5y | 93.2% |
CAGR 5y | 18.80% |
CAGR/Max DD 5y | 1.07 |
Sharpe Ratio 12m | 0.89 |
Alpha | 2.57 |
Beta | 0.000 |
Volatility | 17.17% |
Current Volume | 1.3k |
Average Volume 20d | 9.2k |
As of March 31, 2025, the stock is trading at EUR 47.87 with a total of 1,340 shares traded.
Over the past week, the price has changed by -3.36%, over one month by -9.88%, over three months by -9.20% and over the past year by +6.90%.
Yes. Based on ValueRay Analyses, JPMorgan s (Ireland) ICAV - (XETRA:JRUD) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 90.38 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JRUD as of March 2025 is 52.56. This means that JRUD is currently overvalued and has a potential downside of 9.8%.
JPMorgan s (Ireland) ICAV - has no consensus analysts rating.
According to ValueRays Forecast Model, JRUD JPMorgan s (Ireland) ICAV - will be worth about 56.8 in March 2026. The stock is currently trading at 47.87. This means that the stock has a potential upside of +18.59%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 56.8 | 18.6% |